Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury
Zhenhong Liu(Beijing University of Chinese Medicine), Zhen Yang(Guizhou Normal University), Rong Guo(Sun Yat-sen University), Xiangyun Chen, Pengwen Wang(Beijing University of Chinese Medicine), Haiying Tong(Beijing University of Chinese Medicine), Shanshan Lu(Jiangsu Province Hospital), Tiantian Liu(Beijing University of Chinese Medicine), Xuezhen Han(Beijing University of Chinese Medicine), Yin Yin(Beijing University of Chinese Medicine), Michael X. Zhu(The University of Texas Health Science Center at Houston)
Cited by 80
Related Papers
2-Aminoethoxydiphenyl Borate Is a Common Activator of TRPV1, TRPV2, and TRPV3
|Journal of Biological Chemistry|2004|504
Prevalence of Internet addiction and its association with social support and other related factors among adolescents in China
|Journal of Adolescence|2016|227
Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma
|Hepatology|2019|165
Two Things about COVID-19 Might Need Attention
|Preprints.org|2020|144
Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs
|Expert Opinion on Drug Delivery|2014|123